BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 17934523)

  • 21. 13 cis-retinoic acid regulates cytokine production and inhibits angiogenesis by disrupting endothelial cell migration and tube formation.
    Guruvayoorappan C; Kuttan G
    J Exp Ther Oncol; 2008; 7(3):173-82. PubMed ID: 19066126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
    Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice.
    Hirai K; Sasahira T; Ohmori H; Fujii K; Kuniyasu H
    Int J Cancer; 2007 Feb; 120(3):500-5. PubMed ID: 17066448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of stromal JUNB does not affect tumor growth and angiogenesis.
    Braun J; Strittmatter K; Nübel T; Komljenovic D; Sator-Schmitt M; Bäuerle T; Angel P; Schorpp-Kistner M
    Int J Cancer; 2014 Mar; 134(6):1511-6. PubMed ID: 24027048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells.
    Koshikawa N; Takenaga K; Tagawa M; Sakiyama S
    Cancer Res; 2000 Jun; 60(11):2936-41. PubMed ID: 10850440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of specific response elements of the c-fos promoter and involvement of intermediate transcription factor(s) in the induction of Sertoli cell differentiation (transferrin promoter activation) by the testicular paracrine factor PModS.
    Whaley PD; Chaudhary J; Cupp A; Skinner MK
    Endocrinology; 1995 Jul; 136(7):3046-53. PubMed ID: 7789331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of thymidine kinase driven by an endothelial-specific promoter inhibits tumor growth of Lewis lung carcinoma cells in transgenic mice.
    Dancer A; Julien S; Bouillot S; Pointu H; Vernet M; Huber P
    Gene Ther; 2003 Jul; 10(14):1170-8. PubMed ID: 12833126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice.
    Bequet-Romero M; Ayala M; Acevedo BE; Rodríguez EG; Ocejo OL; Torrens I; Gavilondo JV
    Angiogenesis; 2007; 10(1):23-34. PubMed ID: 17273909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers.
    Kato S; Shimoda H; Ji RC; Miura M
    Anat Sci Int; 2006 Jun; 81(2):71-83. PubMed ID: 16800291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis.
    Caccuri F; Rueckert C; Giagulli C; Schulze K; Basta D; Zicari S; Marsico S; Cervi E; Fiorentini S; Slevin M; Guzman CA; Caruso A
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):846-56. PubMed ID: 24482377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy.
    Sonveaux P; Brouet A; Havaux X; Grégoire V; Dessy C; Balligand JL; Feron O
    Cancer Res; 2003 Mar; 63(5):1012-9. PubMed ID: 12615716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.
    Kopfstein L; Veikkola T; Djonov VG; Baeriswyl V; Schomber T; Strittmatter K; Stacker SA; Achen MG; Alitalo K; Christofori G
    Am J Pathol; 2007 Apr; 170(4):1348-61. PubMed ID: 17392173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory mechanism of vascular endothelial growth factor (VEGF) by bucillamine.
    Koyama S; Takagi H; Otani A; Oh H; Nishimura K; Honda Y
    Br J Pharmacol; 2002 Nov; 137(6):901-9. PubMed ID: 12411422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticancer treatment of endostatin gene therapy by targeting tumor neovasculature in C57/BL mice.
    Jia S; Zhu F; Li H; He F; Xiu R
    Clin Hemorheol Microcirc; 2000; 23(2-4):251-7. PubMed ID: 11321448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The specific effect of 2-methoxyestradiol on lymphatic vascular endothelial cells.
    Imai S; Yoshida Y; Okamura T; Nagano K; Abe Y; Yoshikawa T; Kamada H; Nakagawa S; Tsunoda S; Tsutsumi Y
    Pharmazie; 2009 Mar; 64(3):214-6. PubMed ID: 19348346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo.
    Bos FL; Caunt M; Peterson-Maduro J; Planas-Paz L; Kowalski J; Karpanen T; van Impel A; Tong R; Ernst JA; Korving J; van Es JH; Lammert E; Duckers HJ; Schulte-Merker S
    Circ Res; 2011 Aug; 109(5):486-91. PubMed ID: 21778431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy.
    Palladino M; Gatto I; Neri V; Straino S; Smith RC; Silver M; Gaetani E; Marcantoni M; Giarretta I; Stigliano E; Capogrossi M; Hlatky L; Landolfi R; Pola R
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2867-76. PubMed ID: 24072696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis.
    Clere N; Corre I; Faure S; Guihot AL; Vessières E; Chalopin M; Morel A; Coqueret O; Hein L; Delneste Y; Paris F; Henrion D
    Int J Cancer; 2010 Nov; 127(10):2279-91. PubMed ID: 20143398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 6-(1-Oxobutyl)-5,8-dimethoxy-1,4-naphthoquinone inhibits lewis lung cancer by antiangiogenesis and apoptosis.
    Lee HJ; Lee HJ; Song GY; Li G; Lee JH; Lü J; Kim SH
    Int J Cancer; 2007 Jun; 120(11):2481-90. PubMed ID: 17311288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of dexamethasone on Lewis mice lung cancer cells.
    Geng Y; Wang J; Jing H; Wang HW; Bao YX
    Genet Mol Res; 2014 Aug; 13(3):6827-36. PubMed ID: 25177962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.